Skip to main content
International Journal of Neuropsychopharmacology logoLink to International Journal of Neuropsychopharmacology
. 2025 Aug 18;28(Suppl 2):ii45–ii46. doi: 10.1093/ijnp/pyaf052.091

621. MENTAL HEALTH AUSTRALIA GENERAL CLINICAL TRIAL NETWORK (MAGNET) – CONNECTING KNOWLEDGE FOR BETTER MENTAL HEALTH OUTCOMES

M Berk 1, S Rossell 2, A Barutchu 3, P Batterham 4, A Calear 5, S Clark 6, E Carbines 7, L Darwin 8, C Davey 9, C Haroutonian 10, S Hood 11, R Iyer 12, C Kaylor-Hughes 13, P Kaur 14, S Lavoie 15, A Markus 16, E McDonald 17, C Mihalopoulos 18, K Mills 19, A O’Neil 20, A Rodgers 21, C Schultz 22, D Siskind 23, S Sundram 24
PMCID: PMC12359721

Abstract

Background

Mental Health Australia General Clinical Trials Network (MAGNET) is the first network in Australia dedicated to clinical trials in adult mental health, aiming to advance prevention, diagnosis, treatment, and recovery. Funded through the 2020 Million Minds Mission grant by the Australian Medical Research Future Fund (MRFF), MAGNET’s goal is to facilitate large-scale, coordinated clinical trials at both national and international levels. By fostering collaboration, MAGNET seeks to drive transformative mental health research, addressing critical unmet needs and answering complex questions that require the scale and expertise of a unified network.

Aims & Objectives

MAGNET's overarching vision is to be a leading network internationally for high-quality mental health clinical trials that serve community needs. MAGNET’s mission is to unify and improve adult mental health clinical trial research and translation in Australia. MAGNET aims to create a reusable, sustainable and shared infrastructure to strengthen the capacity, quality, effectiveness, and translation of mental health clinical trials (CTs).

Method

MAGNET is a collaboration between over 50+ Australian institutions and 600+ leading researchers, clinicians, and lived experience research partners in mental health aiming to improve the quality, capacity, reach and translation of clinical trials.

Results

In collaboration with the mental health community, MAGNET has established seven platform resources designed to enhance the quality and capacity of clinical trials.

MAGNET also supports four signature trials, leveraging these platforms to provide essential resources and expertise for trial design and implementation while minimising duplication.

MAGNET has established a trial endorsement process to support transformative mental health research, targeting critical gaps and unresolved questions at both national and international levels. At the core of MAGNET’s governance are Lived Experience Research Partners, First Nations collaborators, researchers, and clinicians, whose active involvement is essential across all aspects of the network. Through strategic planning, MAGNET is committed to ensuring that clinical trials drive significant progress in prevention, diagnosis, treatment, and recovery worldwide.

Discussion & Conclusions

MAGNET is dedicated to enabling scalable, high-quality, and translatable mental health clinical trials that meet community needs. The network warmly invites national and international researchers and partners to collaborate in the development of mental health clinical trials.

graphic file with name f15.jpg


Articles from International Journal of Neuropsychopharmacology are provided here courtesy of Oxford University Press

RESOURCES